Ongoing projects:
Type of Call for Proposals | Name of the Project | Project Unique Identifier / Status of Submitted Applications | Project Title | Principal Investigator | Issuer of the Call for Proposals | Collaborating SE Partner | Collaborating External Partner | SE Coordination | Date of Grant Award | Project Start Date | Project End Date | Amount of awarded fund | Amount of awarded fund by FARMA | I. Mileston Start | I. Mileston End | I. Mileston Budget | II. Milestone Start | II. Milestone End | II. Milestone Budget | III. Milestone Start | III. Milestone End | III. Milestone Budget | IV. Milestone Start | IV. Milestone End | IV. Milestone Budget | V. Milestone Start | V. Milestone End | V. Milestone Budget | VI. Milesotne Start | VI. Milesotne End | VI. Milesotne Budget | Status | Maintenance Obligation | SAP Fund | SAP PST |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Establishment of National Laboratories and complex development grant | Nemzeti_Szivlabor_2022 | National Cardiovascular Laboratory, RRF-2.3.1-21-2022-00003 | Building on the highly successful results of the National Heart Program conducted between 2016 and 2020, the National Cardiovascular Laboratory undertakes revolutionary new research into the pathophysiological mechanisms involved in the development of cardiovascular diseases associated with aging. The aim is to develop and implement new, innovative preventive, diagnostic, and therapeutic procedures based on the results of the research. | Prof. Dr. Béla Merkely | NKFIH | VSZÉK (consortium leader) Népegészségtani Intézet, GSI, BELGYOGY, | Pharmahungary 2000 Kft, Neumann Medical Kft, 3D Histech Kft, Szegedi TE | PMK | 01.04.2022 | 01.03.2022 | 28.02.2026 | 5.670.176.720 Ft | 1.237.500.000 Ft | 01.03.2022 | 30.06.2022 | 42.492.420 Ft | 01.07.2022 | 31.03.2023 | 344.050.720 Ft | 01.04.2023 | 31.03.2024 | 334.247.561 Ft | 01.04.2023 | 31.03.2025 | 260.231.537 Ft | 01.04.2025 | 28.02.2026 | 256.477.763 Ft | ongoing | at least five years from the completion (physical completion) of the project | OPPR | RF0101FARM | |||
Establishment and Development of Competence Centers (2022-1.1.1-KK) | KK_Letrehozasa_2022 | 2022-1.1.1-KK-2022-00005 | Health Industry Competence Center of the Future at Semmelweis University | Péter Ferdinandy, MD, PhD, DSc, MBA | NKFIH | 77Elektronika, Femtonics, Oncompass, Richter | 12.08.2024 | 01.04.2023 | 31.03.2027 | 3.886.027.141 Ft | 473.356.490 Ft | 01.04.2023 | 31.03.2024 | 01.04.2024 | 31.03.2025 | 01.04.2025 | 31.03.2026 | 01.04.2026 | 31.03.2027 | ongoing | 5 years | ELKA | NK0201FARM | ||||||||||||
MTA Research Group support | MTA-TKI_2019 | MTA-SE-Rendszerfarmakológiai Kutatócsoport, 0206607 | Establishment of a System Pharmacology Research Group: Identification of molecular targets of cardioprotection and hidden cardiotoxicity with functional genomics and molecular network analysis of icchemic heart disease and its comorbidities | Péter Ferdinandy, MD, PhD, DSc, MBA | MTA | - | 06.05.2019 | 01.07.2019 | 31.12.2024 | 137.500.000 Ft | 01.07.2019 | 30.06.2020 | 25.000.000 Ft | 01.07.2020 | 30.06.2021 | 25.000.000 Ft | 01.07.2021 | 30.06.2022 | 25.000.000 Ft | 01.07.2022 | 30.06.2023 | 25.000.000 Ft | 01.07.2023 | 30.06.2024 | 25.000.000 Ft | 01.07.2024 | 31.12.2024 | 12.500.000 Ft | extended by six months: until 31.12.2024 | - | - | ||||
Semmelweis Lendület Program Grant 2024 | Belso_Lendulet_FP | SE11594387 | Development of microRNA Therapy for Cardiometabolic and Oncological Diseases | Péter Ferdinandy, MD, PhD, DSc, MBA | Semmelweis University | 15.07.2024 | 14.07.2025 | 50.000.000 Ft | 50.000.000 Ft | 15.07.2024 | 14.07.2025 | 50.000.000 Ft | ongoing | - | LENDFARM01 | ||||||||||||||||||||
LENDÜLET_2021-38 grant | Lendulet_VZ_2021 | LP-2021-14 | Molecular mechanisms of cardiology and onco-cardiology diseases, as well as their therapeutic and diagnostic studies | Dr. Zoltán Varga | MTA | - | 26.11.2021 | 01.12.2021 | 30.11.2026 | 180.002.000 Ft | 01.12.2021 | 30.11.2022 | 33.601.000 Ft | 01.12.2022 | 30.11.2023 | 34.800.000 Ft | 01.12.2023 | 30.11.2024 | 34.800.000 Ft | 01.12.2024 | 30.11.2025 | 38.400.000 Ft | 01.12.2025 | 30.11.2026 | 38.400.000 Ft | ongoing | - | EATV | AK2101FARM | ||||||
Thematic Excellence Program 2021 Therapeutic grant | TKP_Terapias_FIKP_2021 | TKP2021-EGA-23 | Translational research and innovation in the diagnosis and therapy of ischemic heart disease and its comorbidities | Péter Ferdinandy, MD, PhD, DSc, MBA | NKFIH | Orálbiológia, VSZÉK, Transzlációs Medicina, GSI, BIFI | yes | 01.08.2021 | 31.12.2025 | 1.400.000.000 Ft | 332.500.000 Ft | 01.08.2021 | 31.07.2023 | 133.000.000 Ft | 01.08.2023 | 31.07.2025 | 133.000.000 Ft | 01.08.2025 | 31.12.2025 | 66.500.000 Ft | ongoing | no maintenance obligation | ELKA | FE0101FARM | |||||||||||
Thematic Excellence Program 2021 Therapeutic grant | TKP_Idegtudomanyi_Gyertyan_2021 | TKP2021-EGA-25 | Translational research and innovation in the diagnosis and therapy of ischemic heart disease and its comorbidities | Dr. János Réthelyi | Ministry of Innovation and Technology | - | 01.08.2021 | 31.12.2025 | 1.200.000.000 Ft | 80.000.000 Ft | 01.08.2021 | 31.07.2023 | 01.08.2023 | 31.07.2025 | 01.08.2025 | 31.12.2025 | ongoing | no maintenance obligation | |||||||||||||||||
HCEMM | TKP_HCEMM_Nazha_2021 | HCEMM-SU Cardiovascular Comorbidities Research Group | Cardiovascular comorbidities | Nazha Hamdani | HCEMM Nonprofit Kft | 01.01.2022 | 31.12.2026 | 200.000.000 Ft | 200.000.000 Ft | 01.01.2022 | 31.12.2022 | 40.000.000 Ft | 01.01.2023 | 31.12.2023 | 40.000.000 Ft | 01.01.2024 | 31.12.2024 | 40.000.000 Ft | 01.01.2025 | 31.12.2025 | 40.000.000 Ft | 01.01.2026 | 31.12.2026 | 40.000.000 Ft | ongoing | - | |||||||||
FIKP2018 - HCEMM | HCEMM_VZ_2019 | HCEMM-SU Cardiometabolic Immunology Research Group, 739593 | Cardiac inflammation: a new therapeutic target in myocardial dysfunctions | Dr. Zoltán Varga | HCEMM Nonprofit Kft | - | 30.04.2019 | 01.05.2019 | 30.04.2025 | 125.000.000 Ft | 01.05.2019 | 30.04.2020 | 25.000.000 Ft | 01.05.2020 | 30.04.2021 | 25.000.000 Ft | 01.05.2021 | 30.04.2022 | 25.000.000 Ft | 01.05.2022 | 30.04.2023 | 25.000.000 Ft | 01.05.2023 | 30.04.2024 | 25.000.000 Ft | ongoing | - | KOZV | KEIKEG0006 | ||||||
Bolyai scholarship 2023 | BO/00277/23/5 | Adrenal steroid hormone synthesis and endoplasmic reticulum (ER)-mitochondria signaling in heart failure after infarction | Dr. Gábor Mórotz | MTA | 15.06.2023 | 01.09.2023 | 31.08.2026 | 9.000.000 Ft | - | ||||||||||||||||||||||||||
OTKA FK | OTKA-FK_VZ_2020 | OTKA FK 134751 | New inflammatory mechanisms in the development of heart failure | Dr. Zoltán Varga | NKFIH | - | 26.12.2020 | 01.12.2020 | 30.11.2025 | 39.996.000 Ft | 01.12.2020 | 30.11.2021 | 9.999.000 Ft | 01.12.2021 | 30.11.2022 | 9.999.000 Ft | 01.12.2022 | 30.11.2023 | 9.999.000 Ft | 01.12.2023 | 30.11.2025 | 9.999.000 Ft | ongoing | no maintenance obligation | OTKA | OT2006FARM | |||||||||
FK_21 "OTKA" | OTKA-FK_ZZ_2021 | FK 138842 | Analysis of bacterial and bile acid abnormalities in the small intestine caused by non-steroidal anti-inflammatory drugs, and investigation of the effect of cannabinoids on enteropathy | Dr. Zoltán Zádori | NKFIH | - | 28.07.2021 | 01.09.2021 | 31.08.2025 | 38.125.000 Ft | 01.09.2021 | 31.08.2022 | 9.375.000 Ft | 01.09.2022 | 31.08.2023 | 10.000.000 Ft | 01.09.2023 | 31.08.2024 | 9.375.000 Ft | 01.09.2024 | 31.08.2025 | 9.375.000 Ft | ongoing | no maintenance obligation | OTKA | OT2120FARM | |||||||||
K_21 "OTKA" | OTKA-K_GA_2021 | K 139237 | Investigation of hidden cardiotoxicity and cardioprotection in translational cell culture models | Dr. Anikó Görbe | NKFIH | - | 28.07.2021 | 01.09.2021 | 31.08.2025 | 45.983.000 Ft | 01.09.2021 | 31.08.2022 | 12.090.000 Ft | 01.09.2022 | 31.08.2023 | 12.715.000 Ft | 01.09.2023 | 31.08.2024 | 10.714.000 Ft | 01.09.2024 | 31.08.2025 | 10.464.000 Ft | ongoing | no maintenance obligation | OTKA | OT2135FARM | |||||||||
K_21 "OTKA" | OTKA-K_GZ_2021 | K 139105 | Impact of metabolic diseases on extracellular vesicle-based signaling in the cardiovascular system | Dr. Zoltán Giricz | NKFIH | - | 28.07.2021 | 01.09.2021 | 31.08.2025 | 46.960.000 Ft | 01.09.2021 | 31.08.2022 | 11.615.000 Ft | 01.09.2022 | 31.08.2023 | 11.865.000 Ft | 01.09.2023 | 31.08.2024 | 11.865.000 Ft | 01.09.2024 | 31.08.2025 | 11.615.000 Ft | ongoing | no maintenance obligation | OTKA | OT2125FARM | |||||||||
FK_21 "OTKA" | OTKA-FK_ZF_2021 | FK 138389 | Investigation of the role of the glycinergic system in the development of opioid analgesic tolerance | Dr. Ferenc Zádor | NKFIH | - | 28.07.2021 | 01.09.2021 | 31.08.2025 | 39.942.000 Ft | 01.09.2021 | 31.08.2022 | 10.000.000 Ft | 01.09.2022 | 31.08.2023 | 10.000.000 Ft | 01.09.2023 | 31.08.2024 | 9.980.000 Ft | 01.09.2024 | 31.08.2025 | 9.962.000 Ft | ongoing | no maintenance obligation | OTKA | OT2110FARM | |||||||||
OTKA_FK_23 | OTKA-FK_MG_2023 | FK_146163 | Endothelial cells and ER-mitochondria signalling in myocardial infarction-associated microvascular obstruction | Dr. Gábor Mórotz | NKFIH | - | - | - | 21.11.2023 | 01.01.2024 | 31.12.2027 | 44.000.000 Ft | 44.000.000 Ft | 01.01.2024 | 31.12.2024 | 10.680.000 Ft | 01.01.2025 | 31.12.2025 | 12.060.000 Ft | 01.01.2026 | 31.12.2026 | 11.520.000 Ft | 01.01.2027 | 31.12.2027 | 9.740.000 Ft | ongoing | no maintenance obligation | OTKA | OT2308FARM |
Submitted projects:
Type of Call for Proposals | Name of the Project | Project Unique Identifier / Status of Submitted Applications | Project Title | Principal Investigator | Issuer of the Call for Proposals | Collaborating SE Partner | Collaborating External Partner | SE Coordination | Date of Grant Award | Project Start Date | Project End Date | Amount of awarded fund |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HUN-REN Funded Research Groups Program | Under review | MicroRNA therapies for cardiometabolic and oncology diseases | Dr. András Makkos | HUN-REN | University of Szeged | 01.01.2025 | 31.12.2027 | 210.000.000 Ft | ||||
HUN-REN Funded Research Groups Program | Under review | In silico modeling of perturbations propagating on the post-transcriptional regulatory network | Dr. Bence Ágg | HUN-REN | PPKE | 01.01.2025 | 31.12.2027 | 164.268.000 Ft | ||||
MTA Distinguished Guest Scientist Fellowship Programme | VENDEGKUTATO2025-42 | Under review | Investigating Metabolic Dysfunction in Heart Failure with Preserved Ejection Fraction (HFpEF) / A metabolikus diszfunkció vizsgálata megtartott ejekciós frakciójú szívelégtelenségben (HFpEF) | Péter Ferdinandy, MD, PhD, DSc, MBA | MTA | 01.03.2025 | 30.09.2025 | 15.000.000 Ft | ||||
NKKP_advanced | Under review | Dr. Zoltán Giricz | NKFIH | 01.01.2025 | 31.12.2028 | 120.000.000 Ft | ||||||
NKKP_advanced | Under review | Dr. Mahmoud Al-Khrasani | NKFIH | 01.01.2025 | 31.12.2028 | 120.000.000 Ft | ||||||
NKKP_starting | Under review | Dr. Bence Ágg | NKFIH | 01.01.2025 | 31.12.2028 | 100.000.000 Ft | ||||||
NKKP_starting | Under review | Dr. Zsófia Gulyás-Onódi | NKFIH | 01.01.2025 | 31.12.2028 | 100.000.000 Ft | ||||||
NKKP_starting | Under review | Dr. Viktória Tóth | NKFIH | 01.01.2025 | 31.12.2028 | 100.000.000 Ft | ||||||
HU-RIZONT | Under review | Péter Ferdinandy, MD, PhD, DSc, MBA | NKFIH | 01.01.2025 | 31.12.2027 | 400.000.000 Ft | ||||||
HU-RIZONT | Under review | Dr. Zoltán Varga | NKFIH | 01.01.2025 | 31.12.2027 | 400.000.000 Ft | ||||||
MAPS | Under review | Péter Ferdinandy, MD, PhD, DSc, MBA | Swiss National Science Foundation | Lucio Barile | 01.04.2025 | 31.03.2027 | CHF 3 948 749 | |||||
Horizon ERC-2023-SyG | ERC_2023_Prometheus | Under review | Péter Ferdinandy, MD, PhD, DSc, MBA | EU | 01.01.2024 | 31.12.2028 | 216 300 EUR | |||||
ERA4Health, Cardinnov2023 | Under review | Blueprint of Inflammatory Drivers of Heart Failure with Preserved Ejection Fraction | Dr. Zoltán Varga | ERA4Health | HCEMM | Leader: Madrid, Spain, José Javier Fuster - Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P) 2. Milan, Italy, Gianluigi Condorelli - Humanitas Research Hospital (HRH) 3. Paris, France, Jean-Sébastien Hulot - Paris Cardiovascular Research Center, INSERM, UMR970 Team 7 Translational Heart Failure lab 4. Maastricht, the Netherlands, Job Verdonschot - Maastricht University, Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology 5. Budapest, Hungary, Zoltan Varga - Hungarian Center of Excellence for Molecular Medicine | 01.05.2024 | 30.04.2027 | ||||
Horizon ERC-2025-STG | PHARM-INF-HEART | Under review | Dr. Zsófia Gulyás-Onódi | EU | 01.01.2026 | 31.12.2030 | 2 430 000 EUR |
Closed projects:
Type of Call for Proposals | Name of the Project | Project Unique Identifier / Status of Submitted Applications | Project Title | Principal Investigator | Issuer of the Call for Proposals | Collaborating SE Partner | Collaborating External Partner | SE Coordination | Date of Grant Award | Project Start Date | Project End Date | Amount of awarded fund | Amount of awarded fund by FARMA | I. Mileston Start | I. Mileston End | I. Mileston Budget | II. Milestone Start | II. Milestone End | II. Milestone Budget | III. Milestone Start | III. Milestone End | III. Milestone Budget | IV. Milestone Start | IV. Milestone End | IV. Milestone Budget | V. Milestone Start | V. Milestone End | V. Milestone Budget | VI. Milesotne Start | VI. Milesotne End | VI. Milesotne Budget | Status | Maintenance Obligation | SAP Sund | SAP PST |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Richter PhD scholarship | Richter_GT_2020 | - | Identification of new inflammatory mechanisms as therapeutic targets in cardiovascular and metabolic diseases | Dr. Tamás Gergely | Richter Gedeon Talentum Foundation | - | 01.09.2020 | 31.08.2024 | 3.200.000 Ft | 01.09.2020 | 31.01.2021 | 400.000 Ft | 01.02.2021 | 31.08.2021 | 400.000 Ft | 01.09.2021 | 31.01.2022 | 400.000 Ft | 01.02.2022 | 31.08.2022 | 400.000 Ft | closed | - | EATV | NP2006FARM | ||||||||||
Richter PhD ösztöndíj | Richter_SVN_2020 | - | The role of extracellular vesicles in cardioprotective therapies | Dr. Sayour Viktor Nabil | Richter Gedeon Talentum Foundation | - | 01.09.2020 | 31.08.2024 | 3.200.000 Ft | 01.09.2020 | 31.01.2021 | 400.000 Ft | 01.02.2021 | 31.08.2021 | 400.000 Ft | 01.09.2021 | 31.01.2022 | 400.000 Ft | 01.02.2022 | 31.08.2022 | 400.000 Ft | closed | - | EATV | NP2007FARM | ||||||||||
UNKP-23-4-I | ÚNKP-23-4-I-SE-5 | Reverse Cardio-Oncology: Spontaneous Tumor-Survivor Preclinical Models in the Study of Heart Failure Risk | Tamás Kovács | Doctoral School of Semmelweis University | 01.09.2023 | 29.02.2024 | 1.200.000 Ft | 1.200.000 Ft | 01.09.2023 | 29.02.2024 | 1.200.000 Ft | ||||||||||||||||||||||||
UNKP-23-4-I | ÚNKP-23-3-I-SE-21 | Supporting Pharmacovigilance Signal Detection Using Artificial Intelligence-Based Methods Developed for Natural Language Processing and Language Model Creation | Olivér Balogh | Doctoral School of Semmelweis University | 01.09.2023 | 29.02.2024 | 1.200.000 Ft | 1.200.000 Ft | 01.09.2023 | 31.08.2024 | 1.200.000 Ft | ||||||||||||||||||||||||
Supporting Market-Driven Research, Development, and Innovation Projects | Piaci-KFI_Oncompass_2019 | 2019-1.1.1-PIACI-KFI-2019-00367 | Development and Preclinical and Clinical Validation of an Artificial Intelligence-Based Medical Decision Support Tool for Precision Oncology Care | Péter Ferdinandy, MD, PhD, DSc, MBA | NKFIH | Consurtium leader: Oncompass Medicine Hungary Kft, Dél-Pesti Centrumkórház Országos Hematológiai és Infektológiai Intézet | - | 12.12.2019 | 01.01.2020 | 31.12.2023 | 78.536.664 Ft | 01.01.2020 | 31.12.2020 | 21.207.720 Ft | 01.01.2021 | 31.12.2021 | 33.556.332 Ft | 01.01.2022 | 31.12.2022 | 23.772.612 Ft | 01.01.2023 | 31.12.2023 | 0 Ft | closed | until 31.12.2026 | ELKA | PI0101FARM | ||||||||
STIA-KFI-2022 | STIA_OZS_2022 | - | In Vitro Study of Promising Inflammasome Inhibitor Compounds for Drug Repurposing | Dr. Zsófia Gulyás - Onódi | Semmelweis Scientific and Innovation Fund | 13.03.2023 | 01.01.2023 | 31.12.2023 | 4.864.100 Ft | 4.864.100 Ft | 01.01.2023 | 31.12.2023 | 4.864.100 Ft | closed | no maintenance obligation | ||||||||||||||||||||
STIA-KFI-2022 | STIA_TV_2022 | - | Investigation of the Role and Pharmacological Modulation of the IFITM3 Virus Restriction Protein in Heart Failure | Dr. Viktória Tóth | Semmelweis Scientific and Innovation Fund | 01.01.2023 | 31.12.2023 | 5.157.897 Ft | 5.157.897 Ft | 01.01.2023 | 31.12.2023 | 5.157.897 Ft | closed | no maintenance obligation | |||||||||||||||||||||
MTA international conference organization | MTA_nemzetkozi_konf | NKSZ-33/2023 | FAMÉ 2023 | Péter Ferdinandy, MD, PhD, DSc, MBA | MTA | April 2023 | 01.01.2023 | 31.12.2023 | 525.000 Ft | 525.000 Ft | 01.01.2023 | 31.12.2023 | 525.000 Ft | ||||||||||||||||||||||
ÚNKP-22-3-II-SE-70 | UNKP_KT_2022 | ÚNKP-22-3-II-SE-70 | Cardio-Oncology: Combination Use of Immune Checkpoint Inhibitors and PARP Inhibitors to Enhance Antitumor Efficacy and Reduce Cardiotoxic Side Effects | Tamás Kovács | Ministry of Innovation and Technology, NKFIH | 01.09.2022 | 31.08.2023 | 1.200.000 (scholarship) + 288.000 (research) | 01.09.2022 | 31.08.2023 | 1.488.000 Ft | closed | no maintenance obligation | ||||||||||||||||||||||
ÚNKP-22-4-II-SE-3 | UNKP_OZS_2022 | ÚNKP-22-4-II-SE-3 | The Role of Inflammatory Mechanisms in the Pathology of Heart Failure - Inflammasome Priming and Activation in Genetically Induced Cardiomyopathies | Dr. Zsófia Gulyás - Onódi | Ministry of Innovation and Technology, NKFIH | 01.09.2022 | 31.08.2023 | 2.400.000 (scholarship) + 576.000 (research) | 01.09.2022 | 31.08.2023 | 2.976.000 Ft | closed | no maintenance obligation | ||||||||||||||||||||||
ÚNKP-22-3-II-SE-31 | UNKP_KDÁ_2022 | ÚNKP-22-3-II-SE-31 | Advantages and Limitations of Combined Use of Angiotensin and Opioid Receptor Ligands in Chronic Pain Management | Dávid Árpád Karádi | Ministry of Innovation and Technology, NKFIH | 01.09.2022 | 31.08.2023 | 1.200.000 (scholarship) + 288.000 (research) | 01.09.2022 | 31.08.2023 | 1.488.000 Ft | closed | no maintenance obligation | ||||||||||||||||||||||
NTP-NFTÖ-22-B | NTP-NFTÖ_NR_2022 (iroda feladat nincs) | NTP-NFTÖ-22-B-0146 | Investigation of the Cardioprotective Effects of MicroRNA-Loaded Extracellular Vesicles | Regina Nagy | Prime Minister’s Office / Human Resources Support Manager | - | 04.05.2022 | 01.07.2022 | 30.06.2023 | 1.000.000 Ft | 1.000.000 Ft | 01.07.2022 | 30.06.2023 | 1.000.000 Ft | closed | - | |||||||||||||||||||
Investment in the Future (2020-1.1.6-JÖVŐ) | Befektetes_a_jovobe_covid_2021 | 2020-1.1.6-JÖVŐ-2021-00013 | New Diagnostic and Therapeutic Procedures in SARS-CoV-2 (COVID-19) Infection | Prof. Dr. Béla Merkely | NKFIH | VSZÉK, Bioinformatika, Klinikai Kísérleti Kutató- és Humán Élettani Intézet, Biofizika, Sote II. Gyermekklinika | - | 23.03.2021 | 01.04.2021 | 31.03.2023 | 450.000.000 Ft | 40.000.000 Ft | 01.04.2021 | 31.03.2022 | 20.000.000 Ft | 01.04.2022 | 31.03.2023 | 20.000.000 Ft | closed | Until the End of the Second Year Following the Completion Date Recorded in the EPTK System | ELKA | JV0205FARM | |||||||||||||
NTP-NFTÖ-21-B | NTP-NFTÖ_KCS_2021 (iroda feladat nincs) | NTP-NFTÖ-21-B-0300 | The Effect of Hypercholesterolemia on Cardiomyocyte-Derived Extracellular Vesicles | Csenger Kovácsházi | Prime Minister’s Office / Human Resources Support Manager | - | 01.09.2021 | 31.12.2022 | 1.000.000 Ft | 600.000 Ft | 01.07.2021 | 31.12.2022 | 600.000 Ft | closed | - | ||||||||||||||||||||
SE250+ | Tamás Gergely, Csenger Kovácsházi, Dániel Kucsera, Mátyás Pétervári, Eszter Puhl, Viktor Sayour Nabil, Imre Vörös | Semmelweis University | 01.02.2022 | 31.08.2022 | 90,000 HUF per person per month | closed | |||||||||||||||||||||||||||||
ÚNKP-21-3-II-SE-33 | UNKP_HB_2021 | The Role of the Lysophosphatidic Acid 2 (LPA2) Receptor in NSAID-Induced Gastropathy in Rats | Barbara Hrutka | Ministry of Innovation and Technology | - | 01.09.2021 | 31.08.2022 | 1.200.000 Ft | closed | - | |||||||||||||||||||||||||
ÚNKP-21-3-II-SE-14 | UNKP_VI_2021 | Investigation of the Toxicity Mechanism of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin on Human Cardiomyocytes and Human Samples of Chronic Heart Failure | Imre Vörös | Ministry of Innovation and Technology | - | 01.09.2021 | 31.08.2022 | 1.200.000 Ft | closed | - | |||||||||||||||||||||||||
ÚNKP-21-3-II-SE-39 | UNKP_GaspA_2021 | Cognitive Characterization of a Scopolamine-Induced Dementia Model in Rats | Attila Gáspár | Ministry of Innovation and Technology | - | 01.09.2021 | 31.08.2022 | 500.000 Ft | closed | - | |||||||||||||||||||||||||
ÚNKP-21-3-II-SE-68 | UNKP_KD_2021 | The Role of Interleukin-1beta Inhibition in Non-Alcoholic Steatohepatitis in an Aged Animal Model | Dániel Kucsera | Ministry of Innovation and Technology | - | 01.09.2021 | 31.08.2022 | 1.200.000 Ft | closed | - | |||||||||||||||||||||||||
ÚNKP-21-4-II-SE-18 | UNKP_AB_2021 | Improving the Accuracy of Network-Based microRNA Target Prediction by Considering the Effects of Competing Endogenous RNAs | Dr. Bence Ágg | Ministry of Innovation and Technology | - | 01.09.2021 | 31.08.2022 | 2.400.000 Ft | closed | - | |||||||||||||||||||||||||
ÚNKP-21-4-I-SE-6 | UNKP_MA_2021 | Investigation of a Potentially Cardioprotective microRNA (miR-125b) in an In Vivo Mouse Model of Acute Myocardial Infarction | Dr. András Makkos | Ministry of Innovation and Technology | - | 01.09.2021 | 31.08.2022 | 2.400.000 Ft | closed | - | |||||||||||||||||||||||||
Bolyai-ÚNKP | UNKP_Bolyai_VZ_2021 | Investigation of the Interaction Between Neurohormonal Activation and Inflammation in Chronic Heart Failure Using an In Vivo Rat Model | Dr. Zoltán Varga | Ministry of Innovation and Technology | - | closed | - | ||||||||||||||||||||||||||||
STIA_2021 | STIA_GZ_2021 | Investigation of the Direct Cardiac Effects and Therapeutic Potential of Discipline Using High-Speed Microscopy in Cell Culture Models | Dr. Zoltán Giricz | - | 15.11.2021 | 30.06.2022 | 8.528.050 Ft | closed | - | ||||||||||||||||||||||||||
Thematic Excellence Program 2020, National Challenges Subprogram | 2020-4.1.1-TKP2020 (TKP_AI_Mesterseges_Intelligencia_2019) | 61825-69071 | National Challenges Program (exTKP) Translational Biotechnology/Artificial Intelligence TKP-24-1/PALY-2020; BIOimaging, Digital BIOmarker, Translational BIOtechnology, and BIOnics | Péter Ferdinandy, MD, PhD, DSc, MBA | Ministry of Innovation and Technology | Attila Szabó (I.sz. Gyermekgyógyászati Klinika), György Bagdy (Gyógyszerhatástani Intézet) | SE Coordination within the own research group | 13.08.2020 | 01.08.2020 | 31.07.2022 | 252.000.000 Ft | 01.08.2020 | 31.07.2021 | 126.000.000 Ft | 01.08.2021 | 31.07.2022 | 126.000.000 Ft | closed | no maintenance obligation | ELKA | TK2121FARM | ||||||||||||||
Stratégiai K+F műhelyek kiválósága | VEKOP_Ligeti_2017 | VEKOP_2.3.2-16-2016-00002 | Investigation of the molecular mechanisms of tissue-damaging processes | Péter Ferdinandy, MD, PhD, DSc, MBA | Ministry of National Economy / Managing Authority for Regional Development Operational Programs | Professional leader Dr. Erzsébet Ligeti /Dr. Edit Buzás, Péter Ferdinandy, MD, PhD, DSc, MBA, Dr. Miklós Geiszt, Dr. László Hunyady, Dr. Attila Mócsai, Dr. Zoltán Jakus | - | - | 02.06.20217 | 01.07.2017 | 30.06.2022 | 100.000.000 Ft | 01.07.2017 | 30.06.2018 | 17.446.803 Ft | 01.07.2018 | 30.06.2019 | 25.172.030 Ft | 01.07.2019 | 30.06.2020 | 21.172.030 Ft | 01.07.2020 | 30.08.2021 | 21.172.030 Ft | closed | 5 years | OPPR | VE0802FARM | |||||||
National Excellence Program - 2017-1.2.1-NKP-2017-00002 NAP2 | NKP_NAP2_Gyertyan_2017 | 4120665110 | National Brain Research Program/Preclinical validation of mechanisms improving cognitive dysfunction in diseases | Dr. István Gyertyán | National Research, Development and Innovation Fund | Magyar Tudományos Akadémia Kísérleti Orvostudományi Kutatóintézet, | - | 01.12.2017 | 31.05.2022 | 79.998.564 Ft | 01.12.2017 | 30.11.2018 | 26.658.767 Ft | 01.12.2018 | 30.11.2019 | 19.485.097 Ft | 01.12.2019 | 30.11.2020 | 17.585.284 Ft | 01.12.2020 | 30.11.2021 | 16.269.416 Ft | closed | - | ELKA | NA0108FARM | |||||||||
Start-up | Start-up_VZ_2018 | 4120611721 | New inflammatory mechanisms in cardiac dysfunctions | Dr. Zoltán Varga | SE ÁOK | - | January 2018 | 01.02.2018 | 31.05.2022 | 19.600.000 Ft | 3.769.231 Ft | closed | - | FOKT | KUTATFARM1 | ||||||||||||||||||||
TÉT_16-1-2016-0057 | 4120653125 | Investigation of immunomodulatory mechanisms in exosome-mediated cardioprotection | Dr. Zoltán Giricz | National Research, Development and Innovation Fund | Csilla Nagy, Gábor Brenner, Péter Ferdinándy, Anikó Görbe | Slovenian / Dr. Mateja Mancek Keber + 2 persons | 11/30/2016 | 1/1/2017 | 12/31/2018 | 1.906.000 Ft | 1/1/2017 | 12/31/2018 | 1.906.000 Ft | closed | |||||||||||||||||||||
TÉT_16-1-2016-0152 | 4120653129 | Investigation of new therapeutic possibilities for cardiovascular changes caused by aging | Dr. Zoltán Giricz | National Research, Development and Innovation Fund | Gábor Brenner, András Makkos, Éva Sághy, Péter Ferdinándy, Anikó Görbe | Serbian / Nina Japundzic-Zigon | 29.09.2017 | 01.02.2018 | 31.01.2020 | 1.880.000 Ft | 01.02.2018 | 31.01.2020 | 1.880.000 Ft | closed | |||||||||||||||||||||
UNKP - New National Excellence Program | Investigation of the role of cyclooxygenase-2 in non-steroidal anti-inflammatory drug-induced intestinal damage and dysbiosis | Dr. Zoltán Zádori | Semmelweis University | 01.09.2017 | 30.06.2018 | 1.400.000 Ft | 01.09.2017 | 30.06.2018 | 1.400.000 Ft | closed | |||||||||||||||||||||||||
UNKP - New National Excellence Program / 2018 | Investigation of the role of inflammasome activation in heart failure | dr. Zsófia Gulyás-Onódi | Semmelweis University | 01.09.2018 | 30.06.2019 | 1.000.000 Ft | 01.09.2018 | 30.06.2019 | 1.000.000 Ft | closed | |||||||||||||||||||||||||
UNKP - New National Excellence Program / 2019 | The role of new, high-efficacy opioids and peripheral, spinal, and supraspinal mu-opioid receptors in alleviating neuropathic pain | dr. Mihály Balogh | Semmelweis University | 01.09.2018 | 30.06.2019 | 3.000.000 Ft | 01.09.2018 | 30.06.2019 | 3.000.000 Ft | closed | |||||||||||||||||||||||||
UNKP - New National Excellence Program / 2020 | Research of new therapeutic strategies in post-infarction heart failure: the role of neutrophil cell death and the role of spinal and supraspinal mu-opioid receptors in alleviating neuropathic pain | Gábor Koncsos | Semmelweis University | 01.09.2018 | 31.01.2019 | 1.500.000 Ft | 01.09.2018 | 31.01.2019 | 1.500.000 Ft | closed | |||||||||||||||||||||||||
UNKP - New National Excellence Program / 2021 | Neuropeptides in cardioprotection | Éva Sághy | Semmelweis University | 01.12.2018 | 30.06.2019 | 480.000 Ft | closed | ||||||||||||||||||||||||||||
Higher Education Institutional Excellence Program 2018 | 61822-64868 | Therapeutic development | Péter Ferdinandy, MD, PhD, DSc, MBA | Ministry of Human Resources | VSZÉK, GSI, BIFI, Oral, Szemészet | 22.03.2018 | 01.04.2018 | 30.06.2019 | 68.778.000 Ft | 01.04.2018 | 31.10.2018 | 34.389.000 Ft | 01.11.2018 | 28.02.2019 | 34.389.000 Ft | closed | |||||||||||||||||||
FIKP | 61822-64863 | Neurology | dr. János Réthelyi | Ministry of Human Resources | 01.04.2018 | 30.06.2019 | 24.999.999 Ft | 01.04.2018 | 31.10.2018 | 12.500.000 Ft | 01.11.2018 | 28.02.2019 | 12.500.000 Ft | closed | |||||||||||||||||||||
STIA 17 | Infrastructure development of the Translational Hearing Laboratory – expanding clinical, industrial, and academic connections | Dr. Tibor Zelles | Semmelweis Scientific and Innovation Fund | 02.11.2017 | 30.11.2018 | 10.380.146 Ft | 02.11.2017 | 30.11.2018 | 10.380.146 Ft | closed | |||||||||||||||||||||||||
STIA 17 | Investigation of the effect of non-steroidal anti-inflammatory drugs on the bile acid metabolome | Dr. Zoltán Zádori | Semmelweis Scientific and Innovation Fund | 02.11.2017 | 30.11.2018 | 4.709.490 Ft | 02.11.2017 | 30.11.2018 | 4.709.490 Ft | closed | |||||||||||||||||||||||||
STIA 17 | The role of the renin-angiotensin system in the pathomechanism of neurodegenerative and psychiatric disorders - identification of new therapeutic targets | Dr. László Köles | Semmelweis Scientific and Innovation Fund | 02.11.2017 | 30.11.2018 | 5.250.000 Ft | 02.11.2017 | 30.11.2018 | 5.250.000 Ft | closed | |||||||||||||||||||||||||
STIA 17 | Analysis of the effects of spinally administered dipeptidyl peptidase 4 enzyme inhibitors on inflammation-induced thermal hyperalgesia | Dr. Kornél Király | Semmelweis Scientific and Innovation Fund | 02.11.2017 | 30.11.2018 | 5.992.112 Ft | 02.11.2017 | 30.11.2018 | 5.992.112 Ft | closed | |||||||||||||||||||||||||
STIA 17 | Development of IT and e-learning at the Institute of Pharmacology and Pharmacotherapy | Dr. Pál Riba | Semmelweis Scientific and Innovation Fund | 02.11.2017 | 30.11.2018 | 7.671.473 Ft | 02.11.2017 | 30.11.2018 | 7.671.473 Ft | closed | |||||||||||||||||||||||||
STIA Instrument grant | Leica LMD6 laser microdissection device | Péter Ferdinandy, MD, PhD, DSc, MBA | Semmelweis Scientific and Innovation Fund | 06.11.2018 | 30.11.2019 | 49.516.030 Ft | 06.11.2018 | 30.11.2019 | 49.516.030 Ft | closed | |||||||||||||||||||||||||
Semmelweis Scientific and Innovation Fund 2018 Instrument grant | STIA 18 M | 68003F0081 / 68003-13204 | Dual-function laser scattering interference contrast analyzer | Dr. Zoltán Zádori | Semmelweis Scientific and Innovation Fund | 06.11.2018 | 30.11.2019 | 20.104.193 Ft | 06.11.2018 | 30.11.2019 | 20.104.193 Ft | closed | |||||||||||||||||||||||
STIA Instrument grant | Procurement of the “CYTONOTE 6 Wells” device for high-throughput automated examination of tissue-damaging processes | Dr. Anikó Görbe | Semmelweis Scientific and Innovation Fund | 06.02.2019 | 31.12.2019 | 5.949.600 Ft | 06.02.2019 | 31.12.2019 | 5.949.600 Ft | closed | |||||||||||||||||||||||||
STIA Instrument grant | Development of the equipment of the Hungarian Central Extracellular Vesicle Research, Service, and Reference Laboratory with a chromatographic target device | Dr. Zoltán Giricz | Semmelweis Scientific and Innovation Fund | 06.02.2019 | 31.12.2019 | 9.951.732 Ft | 06.02.2019 | 31.12.2019 | 9.951.732 Ft | closed | |||||||||||||||||||||||||
KH17 Otka 125570 | 4120650339 | Identification of drug targets in ischemic heart disease and its comorbidities by bioinformatic prediction of transcriptomic data and experimental validation of targets | Péter Ferdinandy, MD, PhD, DSc, MBA | National Research, Development and Innovation Fund | Éva Sághy, Bence Ágg, András Makkos | 10.07.2017 | 01.10.2017 | 30.09.2019 | 19.670.000 Ft | 01.10.2017 | 30.09.2018 | 4.013.000 Ft | 01.10.2018 | 30.09.2019 | 15.657.000 Ft | closed | |||||||||||||||||||
Otka | 4120611750 | Investigation of extracellular vesicles in cardiovascular diseases with metabolic comorbidities | Dr. Zoltán Giricz | SE ÁOK | 22.11.2018 | 31.05.2019 | 500.000 Ft | 22.11.2018 | 31.05.2019 | 500.000 Ft | closed | ||||||||||||||||||||||||
4120611751 | Investigation of endogenous cardioprotective mechanisms in the context of cardiovascular comorbidities and their pharmacological treatment using innovative cell culture models | Dr. Anikó Görbe | SE ÁOK | 22.11.2018 | 31.05.2019 | 500.000 Ft | 22.11.2018 | 31.05.2019 | 500.000 Ft | closed | |||||||||||||||||||||||||
4120611752 | Investigation of the role of dipeptidyl-peptidase 4 inhibitors and short CART peptide fragments in spinal nociceptive transmission | Dr. Kornél Király | SE ÁOK | 22.11.2018 | 31.05.2019 | 500.000 Ft | 22.11.2018 | 31.05.2019 | 500.000 Ft | closed | |||||||||||||||||||||||||
4120611753 | Hearing and Hearing Loss: Purinergic Signaling and Noise-Induced Hearing Loss | Dr. Tibor Zelles | SE ÁOK | 22.11.2018 | 31.05.2019 | 500.000 Ft | 22.11.2018 | 31.05.2019 | 500.000 Ft | closed | |||||||||||||||||||||||||
EFOP-3.6.3-VEKOP-16-201-00009 | 4120669019 | Development of scientific workshops in medical, health sciences, and pharmaceutical education | Judit Szepesy | Doctoral School of Semmelweis University | 300.000 Ft | closed | |||||||||||||||||||||||||||||
Richter Fundation | Support for participation in scientific events and conferences | Bernadette Lázár | Richter | 25.06.2019 | 28.06.2019 | 200.000 Ft | 200.000 Ft | 25.06.2019 | 28.06.2019 | 200.000 Ft | closed | ||||||||||||||||||||||||
Richter Research Contract | 4.120.667.046 | Development of drugs for the treatment of sensorineural hearing loss | Dr. Tibor Zelles | Richter | 01.09.2018 | 31.12.2020 | 15.240.000 Ft | 01.09.2018 | 31.03.2019 | 8.255.000 Ft | 01.04.2019 | 31.12.2020 | 6.985.000 Ft | closed | |||||||||||||||||||||
National Competitiveness and Excellence Program 2016 | NVKP_16-1-2016-0017 | 41206Z0100 65083 | NVKP National Heart Program: Research and Innovation in the Diagnosis and Therapy of Ischemic Heart Disease and Heart Failure | Péter Ferdinandy, MD, PhD, DSc, MBA | National Research, Development and Innovation Fund | SE Városmajor Szív- és Érgyógyászati Klinika - Farmakológiai és Farmakoterápiás Intézet - Biofizikai és Sugárbiológiai Intézet - Genetikai, Sejt- és Immunbiológiai Intézet | Neumann Projekt és Szervezési Kft, MEDISO Medical Imaging Systems Kft, Pharmahungary 2000 Kft, Twinmed Orvosi Rendszerek Kft, | 18.11.2016 | 01.12.2016 | 30.11.2020 | 485.426.377 Ft | 478.350.888 Ft | 01.12.2016 | 31.05.2018 | 217.493.399 Ft | 01.06.2018 | 30.11.2019 | 226.593.318 Ft | 01.12.2019 | 30.11.2020 | 34.264.171 Ft | closed | |||||||||||||
Thematic Excellence Program 2019 | TKP 2019 | 61825-69071 | Translational Biotechnology/Artificial Intelligence | Péter Ferdinandy, MD, PhD, DSc, MBA | NKFIH | Attila Szabó (I.sz. Gyermekgyógyászati Klinika), György Bagdy (Gyógyszerhatástani Intézet) | 01.05.2019 | 30.06.2020 | 116.000.000 Ft | 01.05.2019 | 31.12.2019 | 116.000.000 Ft | closed | ||||||||||||||||||||||
Higher Education Institutional Excellence Program 2019 | FIKP 2019 | 61826-69036 | Therapeutic Development | Péter Ferdinandy, MD, PhD, DSc, MBA | Ministry of Innovation and Technology | VSZÉK, GSI, BIFI, Oral, Szemészet | 01.07.2019 | 30.06.2020 | 49.406.690 Ft | 01.07.2019 | 30.06.2020 | 49.406.690 Ft | closed | ||||||||||||||||||||||
FIKP 2019 | 61826-69032 | Neurology | dr. János Réthelyi | Ministry of Innovation and Technology | 01.07.2019 | 30.06.2020 | 19.005.125 Ft | 01.07.2019 | 30.06.2020 | 19.005.125 Ft | closed | ||||||||||||||||||||||||
UNKP - New National Excellence Program Higher Education Doctoral Student, Doctoral Candidate Research Scholarship | ÚNKP-19-3-I-SE-11 | Comprehensive Investigation of Inflammatory Pathways in Human Heart Failure | Dr. Zsófia Gulyás-Onódi | Semmelweis University | 01.09.2019 | 30.06.2020 | 1.080.000 Ft | 01.09.2019 | 30.06.2020 | 1.080.000 Ft | closed | ||||||||||||||||||||||||
UNKP - New National Excellence Program Higher Education Doctoral Student, Doctoral Candidate Research Scholarship | ÚNKP-19-3-I-SE-60 | Exploration of Common Regulatory Pathways of Cardioprotective microRNAs | András Makkos | Semmelweis University | 01.09.2019 | 30.06.2020 | 1.080.000 Ft | 01.09.2019 | 30.06.2020 | 1.080.000 Ft | closed | ||||||||||||||||||||||||
UNKP - New National Excellence Program Bolyai+ Higher Education Young Lecturer and Researcher Scholarship for the 2019/2020 Academic Year | ÚNKP-19-4-SE-17 | Investigation of Potentially Cardioprotective Neuropeptides in Ischemic Heart Diseases | Éva Sághy | Semmelweis University | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | closed | ||||||||||||||||||||||||
UNKP - New National Excellence Program Bolyai+ Higher Education Young Lecturer and Researcher Scholarship for the 2019/2020 Academic Year | ÚNKP-19-4-SE-18 | Modeling inflammasome activation in chronic heart failure using in vitro cell culture models | Dr. Zoltán Varga | Semmelweis University | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | closed | ||||||||||||||||||||||||
UNKP - New National Excellence Program Bolyai+ Higher Education Young Lecturer and Researcher Scholarship for the 2019/2020 Academic Year | ÚNKP-19-4-SE-94 | Investigating the effects of obesity on the quantitative and qualitative properties of extracellular vesicles | Dr. Zoltán Giricz | Semmelweis University | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | closed | ||||||||||||||||||||||||
Richter travel support | Support for participation in scientific events and conferences | Judit Szepesy | Richter | 1/24/2020 | 1/29/2020 | 200.000 Ft | 9/1/2019 | 6/30/2020 | 2.000.000 Ft | closed | |||||||||||||||||||||||||
Richter research support | Pharmacological exploration of a new potential pain relief mechanism: Innovative investigation of glycine transporter-1 and glycine transporter-2 inhibitors in various pain models | Mihály Balohg | Richter | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | 01.09.2019 | 30.06.2020 | 2.000.000 Ft | closed | |||||||||||||||||||||||||
STIA_2019 | 6800313311 | Presentation of NAP2 results at international conferences | Dr. Aliz Judit Ernyey | Semmelweis University | 01.01.2020 | 30.06.2020 | 997.540 Ft | 01.01.2020 | 30.06.2020 | 997.540 Ft | closed | ||||||||||||||||||||||||
6800313317 | Changes in the dynamics of cardiac extracellular vesicle communication due to hyperlipidemia | Dr. Zoltán Giricz | Semmelweis University | 01.01.2020 | 30.06.2020 | 7.500.000 Ft | 01.01.2020 | 30.06.2020 | 8.716.000 Ft | closed | |||||||||||||||||||||||||
UNKP - New National Excellence Program for Higher Education Doctoral Students and Doctoral Candidates Research Scholarship | ÚNKP-20-4-I-SE-7 | Development of software based on the principle of hierarchical relative entropy optimization for more efficient visualization of molecular biological networks | Dr. Bence Ágg | Semmelweis University | 01.09.2020 | 31.08.2021 | 3.072.000 Ft | 01.09.2020 | 31.08.2021 | 3.072.000 Ft | closed | ||||||||||||||||||||||||
OTKA FK 124878 | 124878 | Investigation of the role of ACOX-2 and alpha2-adrenoceptors in NSAID-induced intestinal damage and dysbiosis | Dr. Zoltán Zádori | National Research, Development and Innovation Fund | 01.09.2017 | 31.08.2021 | 37.164.000 Ft | 01.09.2017 | 31.08.2018 | 9.480.000 Ft | 01.09.2018 | 31.08.2019 | 9.564.000 Ft | 01.09.2019 | 31.08.2020 | 8.976.000 Ft | 01.09.2020 | 31.08.2021 | 9.144.000 Ft | closed | |||||||||||||||
OTKA NN 126968 | 4120650349 | New butyrylcholinesterase reactivators for the pseudo-catalytic inactivation of organophosphates (BChER) | Dr. Huba Kalász | National Research, Development and Innovation Fund | 01.10.2017 | 30.09.2021 | 26.999.000 Ft | 01.10.2017 | 30.09.2018 | 12.330.000 Ft | 01.10.2018 | 30.09.2019 | 11.089.000 Ft | 01.10.2019 | 31.12.2019 | 3.580.000 Ft | closed | ||||||||||||||||||
UNKP - New National Excellence Program for Higher Education Doctoral Students and Doctoral Candidates Research Scholarship | ÚNKP-20-3-II-SE-73 | Investigation of the effects of selective cyclooxygenase-2 inhibitors in a mesenteric ischemia-reperfusion model in rats | Dr. Szilvia László | Semmelweis University | 01.09.2020 | 31.08.2021 | 1.584.000 Ft | 01.09.2020 | 31.08.2021 | 1.584.000 Ft | closed | ||||||||||||||||||||||||
STIA-KFI-2019 - 2020 | 6.183.069.317 | Applying network theoretic methodologies to reveal immunological comorbidities the response to cardiprotective phamaceutical treatments | Dr. Bence Ágg | Semmelweis University | 01.12.2020 | 31.07.2021 | 8.000.000 Ft | 01.12.2020 | 31.07.2021 | 8.000.000 Ft | closed | ||||||||||||||||||||||||
STIA-KFI-2020 | 6.183.069.325 | Investigation of the effects of hypercholesterolemia on intercellular communication via extracellular vesicles | Dr. Zoltán Giricz | Semmelweis University | 01.12.2020 | 30.09.2021 | 11.608.000 Ft | 01.12.2020 | 30.09.2021 | 11.608.000 Ft | closed | ||||||||||||||||||||||||
STIA-OTKA-2020 | 6.083.169.353 | Establishment of a neurovascular uncoupling model in rats | Dr. István Gyertyán | Semmelweis University | 01.12.2020 | 30.06.2021 | 8.856.600 Ft | 01.12.2020 | 30.06.2021 | 8.856.600 Ft | closed | ||||||||||||||||||||||||
2020-4.1.1-TKP2020 | Higher Education Institutional Excellence Program 2020 | 61830-69278 | FIKP2020 Therapeutic Development | Péter Ferdinandy, MD, PhD, DSc, MBA | Ministry of Innovation and Technology | 01.08.2020 | 31.07.2021 | 49.406.690 Ft | 01.08.2020 | 31.07.2021 | 49.406.690 Ft | closed | |||||||||||||||||||||||
61830-69266 | FIKP2020 Neurology Thematic Area | dr. János Réthelyi | Ministry of Innovation and Technology | 01.08.2020 | 31.07.2021 | 19.005.125 Ft | 01.08.2020 | 31.07.2021 | 19.005.125 Ft | closed | |||||||||||||||||||||||||
Fujimoto research contract | Investigation of the mechanisms of action of enhancer substances (deprenyl and BPAP), and comparative analysis of the effect spectrum of deprenyl and rasagiline | Dr. Ildikó Miklya | FP Pharma Japan | 01.09.2019 | 28.02.2021 | 16.000.000 Ft | 01.09.2019 | 31.05.2020 | 8.000.000 Ft | 01.06.2020 | 28.02.2021 | 8.000.000 Ft | closed | KKUT | KN1453FARM | ||||||||||||||||||||
OTKA K128875 | 128875 | Punireg calcium regulation in the supporting cells of the organ of Corti, and its role in hearing and noise-induced hearing loss | Dr. Tibor Zelles | National Research, Development and Innovation Fund | - | 01.11.2018 | 31.10.2022 | 47.994.000 Ft | 01.11.2018 | 31.10.2019 | 8.412.000 Ft | 01.11.2019 | 31.10.2020 | 13.434.000 Ft | 01.11.2020 | 31.10.2021 | 12.714.000 Ft | 01.11.2021 | 31.10.2022 | 13.434.000 Ft | closed | OTKA | OT1810FARM | ||||||||||||
2018-1.3.1-VKE-2018-00030 | Pharmaceutical technology, pharmacological, and clinical studies conducted with a centrally acting muscle relaxant | Dr. Mahmoud Al-Khrasani | - | 01.01.2019 | 31.12.2021 | 456.616.547 Ft | closed | - | |||||||||||||||||||||||||||
STIA-MEC-2020 | 6.183.169.337 | Publication fee support - Cardiovascular Research | Dr. Zsófia Gulyás-Onódi Zsófia | Semmelweis University | - | 01.12.2020 | 30.06.2021 | 1.000.000 Ft | 01.12.2020 | 30.06.2021 | 1.000.000 Ft | closed | - | KOZV | KEIKEG0024 |